(Q51693436)

9 April 2018

title

Introduction. Expanding the anti-allergy therapeutic horizon. (English)

1 reference

9 April 2018

author name string

Canonica GW

series ordinal

1

1 reference

9 April 2018

publication date

1 January 2002

1 reference

9 April 2018

published in

Allergy

1 reference

9 April 2018

volume

57 Suppl 75

1 reference

9 April 2018

page(s)

5-7

1 reference

9 April 2018

The European Community Respiratory Health Survey: what are the main results so far? European Community Respiratory Health Survey II.

cites work

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.57.S75.1.X

Association between air pollution and daily consultations with general practitioners for allergic rhinitis in London, United Kingdom

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.57.S75.1.X

Allergic sensitization and diet: ecological analysis in selected European cities

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.57.S75.1.X

Allergy and allergic diseases. First of two parts

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.57.S75.1.X

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.57.S75.1.X

Siblings, multiple births, and the incidence of allergic disease: a birth cohort study using the West Midlands general practice research database

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.57.S75.1.X

Quality of life in adults and children with allergic rhinitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.57.S75.1.X

Consensus statement on the treatment of allergic rhinitis. European Academy of Allergology and Clinical Immunology.

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.57.S75.1.X

The impact of chronic urticaria on the quality of life.

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.57.S75.1.X

The economic burden of asthma: direct and indirect costs in Switzerland.

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.57.S75.1.X

Advances in allergy management

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.57.S75.1.X

Asthma control and differences in management practices across seven European countries.

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.57.S75.1.X

Economic consequences of comorbid depression, anxiety, and allergic rhinitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.57.S75.1.X

Allergic rhinitis and its impact on asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.57.S75.1.X

Does Living on a Farm during Childhood Protect against Asthma, Allergic Rhinitis, and Atopy in Adulthood?

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.57.S75.1.X

[Epidemiology and costs of bronchial asthma and chronic bronchitis in Germany]

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.57.S75.1.X

Worldwide variations in prevalence of symptoms of allergic rhinoconjunctivitis in children: the International Study of Asthma and Allergies in Childhood (ISAAC).

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.57.S75.1.X

inferred from DOI database lookup

7 January 2021

based on heuristic

Sedation, cognition, and antihistamines

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.57.S75.1.X

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1034/J.1398-9995.57.S75.1.X

1 reference

9 April 2018

1 reference

9 April 2018